Status:

COMPLETED

B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

Lead Sponsor:

University of Copenhagen

Collaborating Sponsors:

Metabolife

Conditions:

Obesity

Eligibility:

MALE

18-50 years

Phase:

PHASE2

PHASE3

Brief Summary

To investigate the 5-hour acute effect on energy expenditure, substrate oxidation and ad libitum food intake after intake of the Metobes-compound (green tea extract, capsaicin, tyrosine, caffeine). Fu...

Detailed Description

Subjects 22 healthy Danish overweight to obese men (BMI between 25 and 35 kg/m2), 18 to 50 years of age. All subjects must be weight stable (within  3-kg) 2 months prior to study inclusion, non-smoki...

Eligibility Criteria

Inclusion

  • 21 healthy Danish normal-weight to obese men (BMI between 20 and 35 kg/m2), 18 to 50 years of age. All subjects must be weight stable (within  3-kg) 2 months prior to study inclusion, non-smoking, non-athletic and have no daily use of medication.

Exclusion

  • They will be excluded if they do not meet the inclusion criteria and/or the blood pressure is above 165/95 mmHg and/or the ECG is abnormal.

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

End Date :

April 1 2005

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT00302263

Start Date

January 1 2005

End Date

April 1 2005

Last Update

March 14 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Human Nutrition, The Royal Veterinary and Agricultural University

Frederiksberg, Denmark, 1958